1. Home
  2. COO vs MDAIW Comparison

COO vs MDAIW Comparison

Compare COO & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COO
  • MDAIW
  • Stock Information
  • Founded
  • COO 1980
  • MDAIW N/A
  • Country
  • COO United States
  • MDAIW United States
  • Employees
  • COO N/A
  • MDAIW 78
  • Industry
  • COO Ophthalmic Goods
  • MDAIW Medical/Dental Instruments
  • Sector
  • COO Health Care
  • MDAIW Health Care
  • Exchange
  • COO Nasdaq
  • MDAIW Nasdaq
  • Market Cap
  • COO N/A
  • MDAIW N/A
  • IPO Year
  • COO N/A
  • MDAIW 2021
  • Fundamental
  • Price
  • COO $93.27
  • MDAIW $0.46
  • Analyst Decision
  • COO Buy
  • MDAIW
  • Analyst Count
  • COO 12
  • MDAIW 0
  • Target Price
  • COO $117.00
  • MDAIW N/A
  • AVG Volume (30 Days)
  • COO 1.3M
  • MDAIW N/A
  • Earning Date
  • COO 03-06-2025
  • MDAIW N/A
  • Dividend Yield
  • COO N/A
  • MDAIW N/A
  • EPS Growth
  • COO 32.43
  • MDAIW N/A
  • EPS
  • COO 1.96
  • MDAIW N/A
  • Revenue
  • COO $3,895,400,000.00
  • MDAIW N/A
  • Revenue This Year
  • COO $6.95
  • MDAIW N/A
  • Revenue Next Year
  • COO $6.65
  • MDAIW N/A
  • P/E Ratio
  • COO $47.59
  • MDAIW N/A
  • Revenue Growth
  • COO 8.41
  • MDAIW N/A
  • 52 Week Low
  • COO $84.76
  • MDAIW N/A
  • 52 Week High
  • COO $112.38
  • MDAIW N/A
  • Technical
  • Relative Strength Index (RSI)
  • COO 48.58
  • MDAIW N/A
  • Support Level
  • COO $88.63
  • MDAIW N/A
  • Resistance Level
  • COO $92.04
  • MDAIW N/A
  • Average True Range (ATR)
  • COO 1.92
  • MDAIW 0.00
  • MACD
  • COO 0.44
  • MDAIW 0.00
  • Stochastic Oscillator
  • COO 74.60
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: